Projects by Sun Pharmaceutical Industries Limited in
Project Information
5028
Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Ltd Has Got Final Approval From The USFDA For Its Abbreviated New Drug Application For Generic Version Of Depo-Testosterone Injection, Testosterone Cypionate Injection USP, 100 Mg/Ml And 200mg/Ml. The Drug Was Indicated For Replacement Therapy In Males For Conditions Associated With Symptoms Of Deficiency Or Absence Of Endogenous Testosterone And The Product Generated Annual Revenue Of Nearly $130 Million In The US. Sun Pharmaceutical Industries Limited Is An Indian Global Pharmaceutical Company, Manufactures And Sells Pharmaceutical Formulations And Active Pharmaceutical Ingredients.
Project Value
Refer document
Clearances Approved
Not Specified
India
Disclaimer :
We takes all possible care for accurate & authentic tender information, however Users are requested to refer Original source of Tender Notice / Tender Document published by Tender Issuing Agency before taking any call regarding this tender.
